Plosbrio
Plosbrio is Novo Nordisk's own lower-priced twin of Ozempic, the identical medicine sold under a different brand name. Health Canada approved it on December 22, 2025 and Novo has not launched it in the 278 days since. Facts as of 2026-09-26.
canada: approved 2025-12-22; not launched as of 2026-07 · us: not applicable
Verified prices
No verified pharmacy price on file yet. Status: approved 2025-12-22; not launched as of 2026-07. This page updates the moment a verified price lands.
Common questions
What is Plosbrio?
Plosbrio is Novo Nordisk's own lower-priced version of Ozempic. Same molecule, same company, different brand name and an intended lower price. It is not a generic made by a competitor. Approved in Canada on December 22, 2025.
Can I buy Plosbrio?
No. It has been approved and unlaunched for 278 days. Health Canada's database still lists every one of its product numbers as approved rather than marketed, and we check that daily.
What is Plosbrio?
Plosbrio is Novo Nordisk's own lower-priced twin of Ozempic, the identical medicine sold under a different brand name. Health Canada approved it on December 22, 2025 and Novo has not launched it in the 278 days since.
How much does Plosbrio cost?
No verified pharmacy price on file yet. Status: approved 2025-12-22; not launched as of 2026-07 in Canada, not applicable in the US. This page updates the moment a verified price lands.
Is Plosbrio available in Canada?
Canadian status: approved 2025-12-22; not launched as of 2026-07.
Is Plosbrio available in the US?
US status: not applicable.
PRICE ALERT
All alerts →Plosbrio is approved, not yet sold. We'll email you the day a price exists.
Setting an alert subscribes you to The Downtick, the twice-weekly brief. Unsubscribe anytime; one link does both.